Cargando…
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
Autores principales: | Eriksson, Reetta A. E., Nieminen, Tiina, Galibert, Lionel, Peltola, Sanna K., Tikkanen, Petra, Käyhty, Piia, Leinonen, Hanna M., Oruetxebarria, Igor, Lepola, Saana, Valkama, Anniina J., Lipponen, Eevi M., Lesch, Hanna P., Ylä-Herttuala, Seppo, Airenne, Kari J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021287/ https://www.ncbi.nlm.nih.gov/pubmed/36936246 http://dx.doi.org/10.3389/fmed.2023.1143748 |
Ejemplares similares
-
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2022) -
Development of Large-Scale Downstream Processing for Lentiviral Vectors
por: Valkama, Anniina J., et al.
Publicado: (2020) -
Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production
por: Leinonen, Hanna M., et al.
Publicado: (2020) -
Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells
por: Leinonen, Hanna M., et al.
Publicado: (2019) -
Functional roles of the membrane-associated AAV protein MAAP
por: Galibert, Lionel, et al.
Publicado: (2021)